Santen Pharmaceutical
North America, California, United States, Emeryville
Description
Santen sells ophthalmic products.
Investor Profile
Santen Pharmaceutical has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Japan, Singapore.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series A (22%)
- Series B (22%)
- Series C (11%)
- Series F (11%)
- Debt Financing (11%)
- Series Unknown (11%)
- Corporate Round (11%)
Country Focus
- United States (67%)
- Japan (22%)
- Singapore (11%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Medical
- Pharmaceutical
- Therapeutics
- Laser
- Semiconductor
- Eyewear
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
